- $499.19m
- $470.91m
- $320.17m
U.S. RESEARCH ROUNDUP-Airbnb, BlackRock, Veritex Holdings
AngioDynamics Inc reports results for the quarter ended May 31 - Earnings Summary
Medical device maker AngioDynamics beats Q4 revenue estimates
AngioDynamics Inc expected to post a loss of 12 cents a share - Earnings Preview
AngioDynamics Inc reports results for the quarter ended February 28 - Earnings Summary
AngioDynamics Inc expected to post a loss of 13 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Antero Resources, IGM Biosciences, Lennar
U.S. STOCKS ON THE MOVE-Axon, AngioDynamics, Phreesia
AngioDynamics rises after forecasting smaller loss for 2025
AngioDynamics Inc reports results for the quarter ended November 30 - Earnings Summary
Brief: AngioDynamics Q2 Adjusted EPS USD -0.04
AngioDynamics Inc expected to post a loss of 11 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Apollo, Hershey, RH
U.S. STOCKS ON THE MOVE-Warner Bros, Seres Therapeutics, Enterprise Bancorp
U.S. STOCKS ON THE MOVE-Tesla, Nvidia, Palantir
U.S. STOCKS ON THE MOVE-Reddit, Dow, Macy's
AngioDynamics rises on US FDA clearance of prostate cancer treatment device
Brief: AngioDynamics Q1 Adjusted EPS USD -0.11
Morning Bid Americas: Dollar surges as European, Japan hawks coo